ISBRA 2006 World Congress on Alcohol Research

Session Details

The new biomarkers of ethanol intake - how to identify, how to use, when to use

Sunday, 10 September 2006 13:30 -15:00

Ballroom 3

Chair M Raj Lakshman Lipid Research laboratory, DVA Medical Center & The George Washington University, Washington, D.CUnited States
Co-Chair Friedrich Wurst Psychiatric University Clinic, BaselSwitzerland

Direct ethanol metabolites such as ethyl glucuronide (EtG), ethyl sulfate (EtS), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) - Their use in diagnosis and treatment
  • Friedrich M Wurst, Psychiatric University Clinic, Switzerland
  • Application of emerging biomarkers in an emergency room setting and in trauma patients
  • Tim Neumann, Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universi, Germany
  • Markers of liver dysfunction in hazardous drinkers
  • John B Whitfield, Royal Prince Alfred Hospital, Australia
  • Proteomic Analysis for Markers of Hazardous/Harmful Drinking
  • Boris Tabakoff, University of Colorado School of Medicine, United States
  • Plasma Sialic Acid Index Of Apoj Is A Viable Marker For Chronic Alcohol Consumption
  • M Raj Lakshman, Lipid Research laboratory, DVA Medical Center & The George Washington University, Washington, D.C, United States
  • Published on Thursday, 7 September 2006 by the Professional Conference Organiser